Jones RB - Search Results

1

New strategies in marrow purging for breast cancer patients receiving high-dose chemotherapy with autologous bone marrow transplantation.

Shpall EJ, Stemmer SM, Bearman SI, Myers S, Purdy M, Jones RB. Shpall EJ, et al. Among authors: jones rb. Breast Cancer Res Treat. 1993;26 Suppl:S19-23. doi: 10.1007/BF00668356. Breast Cancer Res Treat. 1993. PMID: 7691269 Clinical Trial.

2

Prognostic model for relapse after high-dose chemotherapy with autologous stem-cell transplantation for stage IV oligometastatic breast cancer.

Nieto Y, Nawaz S, Jones RB, Shpall EJ, Cagnoni PJ, McSweeney PA, Barón A, Razook C, Matthes S, Bearman SI. Nieto Y, et al. Among authors: jones rb. J Clin Oncol. 2002 Feb 1;20(3):707-18. doi: 10.1200/JCO.2002.20.3.707. J Clin Oncol. 2002. PMID: 11821452

3

High-dose chemotherapy for breast cancer: is another look warranted?

Nieto Y, Jones RB, Shpall EJ. Nieto Y, et al. Among authors: jones rb. Curr Opin Oncol. 2004 Mar;16(2):114-9. doi: 10.1097/00001622-200403000-00005. Curr Opin Oncol. 2004. PMID: 15075901 Review.

4

Long-term analysis and prospective validation of a prognostic model for patients with high-risk primary breast cancer receiving high-dose chemotherapy.

Nieto Y, Nawaz S, Shpall EJ, Bearman SI, Murphy J, Jones RB. Nieto Y, et al. Among authors: jones rb. Clin Cancer Res. 2004 Apr 15;10(8):2609-17. doi: 10.1158/1078-0432.ccr-03-0536. Clin Cancer Res. 2004. PMID: 15102662

5

Prognostic analysis of early lymphocyte recovery in patients with advanced breast cancer receiving high-dose chemotherapy with an autologous hematopoietic progenitor cell transplant.

Nieto Y, Shpall EJ, McNiece IK, Nawaz S, Beaudet J, Rosinski S, Pellom J, Slat-Vasquez V, McSweeney PA, Bearman SI, Murphy J, Jones RB. Nieto Y, et al. Among authors: jones rb. Clin Cancer Res. 2004 Aug 1;10(15):5076-86. doi: 10.1158/1078-0432.CCR-04-0117. Clin Cancer Res. 2004. PMID: 15297410

6

Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer.

Nieto Y, Vredenburgh JJ, Shpall EJ, Bearman SI, McSweeney PA, Chao N, Rizzieri D, Gasparetto C, Matthes S, Barón AE, Jones RB. Nieto Y, et al. Among authors: jones rb. Clin Cancer Res. 2004 Nov 1;10(21):7136-43. doi: 10.1158/1078-0432.CCR-04-0891. Clin Cancer Res. 2004. PMID: 15534084 Clinical Trial.

7

Evaluation of the effect of age on treatment-related mortality and relapse in patients with high-risk primary breast cancer receiving high-dose chemotherapy.

Nieto Y, Shpall EJ, Bearman SI, Jones RB. Nieto Y, et al. Among authors: jones rb. Am J Clin Oncol. 2005 Jun;28(3):248-54. doi: 10.1097/01.coc.0000145349.12537.13. Am J Clin Oncol. 2005. PMID: 15923796

8

Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.

Shpall EJ, Stemmer SM, Johnston CF, Hami L, Bearman SI, Berenson R, Jones RB. Shpall EJ, et al. Among authors: jones rb. J Hematother. 1992 Spring;1(1):45-54. doi: 10.1089/scd.1.1992.1.45. J Hematother. 1992. PMID: 1365017 Review.

9

Treatment of breast cancer in the 1990s. What does the future hold?

Jones RB, Shpall EJ. Jones RB, et al. Drugs. 1992 Feb;43(2):141-5. doi: 10.2165/00003495-199243020-00001. Drugs. 1992. PMID: 1372213 Review. No abstract available.

10

High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity.

Jones RB, Shpall EJ, Ross M, Coniglio D, Affronti ML, Peters WP. Jones RB, et al. Cancer Chemother Pharmacol. 1990;26(2):155-6. doi: 10.1007/BF02897264. Cancer Chemother Pharmacol. 1990. PMID: 2189592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

879 results

Search Page

Filters